MedPath

淄博万杰制药有限公司

Ownership
-
Established
2009-04-24
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

NMPA:12

Drug Approvals

Pemetrexed DIodium

Product Name
培美曲塞二钠
Approval Number
国药准字H20080262
Approval Date
Jan 9, 2024
NMPA

Telmisartan Tablets

Product Name
曲亚
Approval Number
国药准字H20050503
Approval Date
Nov 3, 2021
NMPA

Telmisartan Tablets

Product Name
曲亚
Approval Number
国药准字H20050504
Approval Date
Nov 3, 2021
NMPA

Doxifluridine

Product Name
去氧氟尿苷
Approval Number
国药准字H20010177
Approval Date
Mar 10, 2020
NMPA

Omeprazole Enteric-coated Capsules

Product Name
克迪圣
Approval Number
国药准字H20023426
Approval Date
Mar 10, 2020
NMPA

Terazosin Hydrochloride Capsules

Product Name
可派
Approval Number
国药准字H19991111
Approval Date
Mar 10, 2020
NMPA

Omeprazole Enteric-coated Capsules

Product Name
克迪圣
Approval Number
国药准字H37022369
Approval Date
Mar 10, 2020
NMPA

Azithromycin Dispersible Tablets

Product Name
派芬
Approval Number
国药准字H20010022
Approval Date
Mar 10, 2020
NMPA

Dextromethorphan Hydrobromide Dispersible Tablets

Product Name
迈生
Approval Number
国药准字H10970225
Approval Date
Mar 10, 2020
NMPA

Doxifluridine Capsules

Product Name
奇诺必通
Approval Number
国药准字H20010180
Approval Date
Mar 10, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.